By Bob Bohrer I have previously posted on pharmaceuticalpolicy.blogspot.com about the FDA’s proposed change to the rules for generic drug labels and an estimate of the liability costs that might be incurred by the generic drug industry as a result of the proposed change. The Generic Pharmaceutical Manufactuer’s Association lobbying efforts appear to have motivated…
SG Global Chat Harvard Effective Altruism — Using Evidence and Reason to Maximize the Impact of Efforts to Make the World Better October 8, 2014 12:30-1:20pm, Kresge G-2 Harvard Effective Altruism (HEA) is a student group at Harvard College and Harvard Business School. The group is dedicated to spreading the ideas of effective altruism to…
Check out Dov Fox‘s new op-ed on racial sorting in family formation over at Huffington Post: Reproducing Race. The piece was prompted by this week’s news of the white lesbian mother who sued a sperm bank for mixing up the sample she ordered with that from a black donor. The impulse to call one’s mixed-race…
By Amanda C. PustilnikI am excited to join the Petrie-Flom Center as the first Senior Fellow in Law & Applied Neuroscience. This fellowship is the product of an innovative partnership between the Petrie-Flom Center and the Center for Law, Brain and Behavior (CLBB) at Massachusetts General Hospital. This partnership aims to translate developments in neuroscience…
By Diana R. H. Winters [Cross-posted at HealthLawProf Blog.] On Thursday, October 2, 2014, FDA released its “Summary Report on Antimicrobials Sold or Distributed in Food-Producing Animals” for 2012. The Report contains the depressing news that “domestic sales and distribution of medically important antimicrobials approved for use in food-producing animals increased by 16%,” between 2009…
By Arthur Caplan Art Caplan and his colleague Alison Bateman-House have a new post in Time about government authority to quarantine individuals who pose a risk of infecting others, and the practical logistics of carrying out a quarantine. Take a look here: Ebola in America: Government Can Lock Us Up for Weeks at a Time
Check out the October 3rd edition of the Petrie-Flom Center’s biweekly e-newsletter for the latest on events, affiliate news and scholarship, and job and fellowship opportunities in health law policy and bioethics.
By Wendy Parmet [Cross-posted from HealthLawProf Blog.] The warning by the Centers for Medicare and Medicaid Services (CMS) last month that up to 115,000 people might lose their health insurance under the Affordable Care Act (ACA) unless they can send proof of their citizenship or immigration status was more than a bit ironic. After spending much of…
By Kate Greenwood[Cross-posted at Health Reform Watch] Earlier this week, the Food and Drug Administration announced that it was reopening the comment periods for the two draft guidances on the use of social media to promote prescription drugs and medical devices that it released in June: Internet/Social Media Platforms with Character Space Limitations: Presenting Risk and Benefit…
By Vadim Shteyler In a previous blog post, I introduced Dutee Chand, a world-class sprinter suspended from national and international competitions by the International Olympic Committee (IOC) and the International Association of Athletics Federations (IAAF). According to the policies of these organizations, an athlete with testosterone levels in the male range cannot compete in the…
